Your browser doesn't support javascript.
loading
Impact of Administering Buprenorphine to Overdose Survivors Using Emergency Medical Services.
Carroll, Gerard; Solomon, Keisha T; Heil, Jessica; Saloner, Brendan; Stuart, Elizabeth A; Patel, Esita Y; Greifer, Noah; Salzman, Matthew; Murphy, Emily; Baston, Kaitlan; Haroz, Rachel.
Afiliação
  • Carroll G; Department of Emergency Medicine, Cooper University Health Care, Camden, NJ. Electronic address: Carroll-Gerard@cooperhealth.edu.
  • Solomon KT; Johns Hopkins Bloomberg School of Public Health, Baltimore, MD.
  • Heil J; Division of Addiction, Cooper University Health Care, Camden, NJ.
  • Saloner B; Johns Hopkins Bloomberg School of Public Health, Baltimore, MD.
  • Stuart EA; Johns Hopkins Bloomberg School of Public Health, Baltimore, MD.
  • Patel EY; Johns Hopkins Bloomberg School of Public Health, Baltimore, MD.
  • Greifer N; Harvard University Institute for Quantitative Social Science, Cambridge, MA.
  • Salzman M; Department of Emergency Medicine, Cooper University Health Care, Camden, NJ.
  • Murphy E; Department of Emergency Medicine, Cooper University Health Care, Camden, NJ.
  • Baston K; Division of Addiction, Cooper University Health Care, Camden, NJ.
  • Haroz R; Department of Emergency Medicine, Cooper University Health Care, Camden, NJ.
Ann Emerg Med ; 81(2): 165-175, 2023 Feb.
Article em En | MEDLINE | ID: mdl-36192278
ABSTRACT
STUDY

OBJECTIVE:

To evaluate the efficacy and safety of utilizing emergency medical services units to administer high dose buprenorphine after an overdose to treat withdrawal symptoms, reduce repeat overdose, and provide a next-day substances use disorder clinic appointment to initiate long-term treatment.

METHODS:

This was a retrospective matched cohort study of patients who experienced an overdose and either received emergency medical services care from a buprenorphine-equipped ambulance or a nonbuprenorphine-equipped ambulance in Camden, New Jersey, an urban community with high overdose rates. There were 117 cases and 123 control patients in the final sample.

RESULTS:

Compared with a nonbuprenorphine-equipped ambulance, exposure to a buprenorphine-equipped ambulance was associated with greater odds of engaging in opioid use disorder treatment within 30 days of an emergency medical services encounter (unadjusted odds ratio 5.62, 95% confidence interval, 2.36 to 13.39). Buprenorphine-equipped ambulance engagement did not decrease repeat overdose compared to the comparison group. Patients who received buprenorphine experienced a decrease in withdrawal symptoms. Their clinical opiate withdrawal scale score decreased from an average of 9.27 to 3.16. buprenorphine-equipped ambulances increased on-scene time by 6.12 minutes.

CONCLUSION:

Patients who encountered paramedics trained to administer buprenorphine and able to arrange prompt substance use disorder treatment after an acute opioid overdose demonstrated a decrease in opioid withdrawal symptoms, an increase in outpatient addiction follow-up care, and showed no difference in repeat overdose. Patients receiving buprenorphine in the out-of-hospital setting did not experience precipitated withdrawal. Expanded out-of-hospital treatment of opiate use disorder is a promising model for rapid access to buprenorphine after an overdose in a patient population that often has limited contact with the health care system.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndrome de Abstinência a Substâncias / Buprenorfina / Serviços Médicos de Emergência / Overdose de Drogas / Transtornos Relacionados ao Uso de Opioides Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndrome de Abstinência a Substâncias / Buprenorfina / Serviços Médicos de Emergência / Overdose de Drogas / Transtornos Relacionados ao Uso de Opioides Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article